Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc/ US46333X1081 /
IRWD
|
2024-05-01 10:00:00 PM
|
Chg.
+0.4700
|
Volume |
Bid11:38:49 PM |
Ask11:38:49 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
8.2200USD
|
+6.06%
|
3.38 mill.
Turnover: 20.2 mill. |
8.1100Bid Size: 500 |
8.4900Ask Size: 200 |
1.29 bill.USD |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-6.45 USD |
-670.80% |
| EPS Diluted: |
-6.45 USD |
- |
| Revenues per Share: |
2.83 USD |
6.19% |
| Book Value per Share: |
-2.21 USD |
- |
| Cash Flow per Share: |
1.17 USD |
-34.01% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
442.74 USD |
7.83% |
| Net Income: |
-1,002.24 USD |
-672.50% |
| Operating Cash Flow: |
183.43 USD |
- |
| Cash and Cash Equivalents: |
92.15 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
2.91 |
4.04 |
| P/BV ratio: |
-3.72 |
-5.17 |
| P/CF Ratio: |
7.01 |
9.76 |
| PEG: |
0.00 |
- |
| Earnings Yield: |
-78.47% |
-56.38% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
1.29 bill. USD |
1.79 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
156.53 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
-213.54% |
| Net Profit Margin: |
-226.37% |
| Return on Equity: |
- |
| Return on Assets: |
-212.76% |
Financial Strength
| Liquidity I / Cash Ratio: |
33.38% |
| Liquidity II / Quick Ratio: |
80.14% |
| Liquidity III / Current Ratio: |
84.49% |
| Debt / Equity Ratio: |
- |
| Dynam. Debt / Equity Ratio: |
445.61% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
US GAAP |
